FDG-PET/CT in the staging of local/regional metastases in breast cancer

被引:53
|
作者
Robertson, Ian J. [1 ]
Hand, Fiona [1 ]
Kell, Malcolm R. [1 ]
机构
[1] Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
来源
BREAST | 2011年 / 20卷 / 06期
关键词
FDG-PET/CT; Breast cancer; Local/regional metastases; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE BIOPSY; MANAGEMENT; SCAN;
D O I
10.1016/j.breast.2011.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the commonest female malignancy in the Western world and the most reliable predictor for survival is axillary lymph node metastases. Conventional staging techniques employed in breast cancer include mammography, ultrasonography, isotope bone scanning, sentinel lymph node biopsy, axillary lymph node dissection and magnetic resonance imaging. More recently FDG-PET and FDG-PET/CT have been used to complement the above methods. This review assesses the role of FOG-PET/CT in axillary staging ill patients with primary breast cancer. A PubMed search was conducted and all articles containing relevant or new information were included. Relevant studies examined identified that FOG-PET/CT has a sensitivity of 60% and a specificity of 97% in detecting lymphatic metastasis. Although positive axillary FOG-PET/CT is a good predictor of axillary disease and correlates well with SLNB, the relatively poor sensitivity (60%) must be considered for treatment planning. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 50 条
  • [41] A Quantitative review of the use of FDG-PET in the axillary staging of breast cancer
    Sloka, J. Scott
    Hollett, Peter D.
    Mathews, Maria
    [J]. MEDICAL SCIENCE MONITOR, 2007, 13 (03): : RA37 - RA46
  • [42] FDG-PET for axillary lymph node staging in primary breast cancer
    Crippa, F
    Gerali, A
    Alessi, A
    Agresti, R
    Bombardieri, E
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (Suppl 1) : S97 - S102
  • [43] Impact of FDG-PET scan on the staging and management of patients with breast cancer
    Ho, G. F.
    Rostom, A.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (04) : S3 - S3
  • [44] FDG-PET for axillary lymph node staging in primary breast cancer
    Flavio Crippa
    Alberto Gerali
    Alessandra Alessi
    Roberto Agresti
    Emilio Bombardieri
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : S97 - S102
  • [45] Breast cancer: initial workup and staging with FDG PET/CT
    Groheux, David
    Hindie, Elif
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2021, 9 (03) : 221 - 231
  • [46] Prognostic value of staging FDG PET/CT in breast cancer
    Han, E.
    Oh, J.
    O, J.
    Park, Y.
    Kang, S.
    Chung, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S354 - S354
  • [47] Breast cancer: initial workup and staging with FDG PET/CT
    David Groheux
    Elif Hindie
    [J]. Clinical and Translational Imaging, 2021, 9 : 221 - 231
  • [48] The Contribution of FDG PET/CT in Diagnosis and Staging of Breast Cancer
    Arslan, E.
    Cermik, T.
    Trabulus, F. Can
    Talu, E. Kelten
    Basaran, S. Tuter
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S629 - S630
  • [49] Initial experience with FDG-PET/CT in the evaluation of breast cancer
    Mitsuaki Tatsumi
    Christian Cohade
    Karen A. Mourtzikos
    Elliot K. Fishman
    Richard L. Wahl
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 254 - 262
  • [50] Initial experience with FDG-PET/CT in the evaluation of breast cancer
    Tatsumi, M
    Cohade, C
    Mourtzikos, K
    Fishman, EK
    Wahl, RL
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (03) : 254 - 262